Keith Thomas Flaherty, M.D.
This page shows the publications co-authored by Keith Flaherty and Marc Michaelson.
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy. Cancer. 2012 Dec 15; 118(24):6055-62.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.